• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell. Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States

tetano

Editor, Senior Moderator
Cell. 2020 May 4. pii: S0092-8674(20)30484-0. doi: 10.1016/j.cell.2020.04.021. [Epub ahead of print]
Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States.


Fauver JR[SUP]1[/SUP], Petrone ME[SUP]2[/SUP], Hodcroft EB[SUP]3[/SUP], Shioda K[SUP]2[/SUP], Ehrlich HY[SUP]2[/SUP], Watts AG[SUP]4[/SUP], Vogels CBF[SUP]2[/SUP], Brito AF[SUP]2[/SUP], Alpert T[SUP]5[/SUP], Muyombwe A[SUP]6[/SUP], Razeq J[SUP]6[/SUP], Downing R[SUP]6[/SUP], Cheemarla NR[SUP]7[/SUP], Wyllie AL[SUP]2[/SUP], Kalinich CC[SUP]2[/SUP], Ott IM[SUP]8[/SUP], Quick J[SUP]9[/SUP], Loman NJ[SUP]9[/SUP], Neugebauer KM[SUP]5[/SUP], Greninger AL[SUP]10[/SUP], Jerome KR[SUP]10[/SUP], Roychoudhury P[SUP]10[/SUP], Xie H[SUP]11[/SUP], Shrestha L[SUP]11[/SUP], Huang ML[SUP]10[/SUP], Pitzer VE[SUP]2[/SUP], Iwasaki A[SUP]12[/SUP], Omer SB[SUP]13[/SUP], Khan K[SUP]14[/SUP], Bogoch II[SUP]15[/SUP], Martinello RA[SUP]16[/SUP], Foxman EF[SUP]17[/SUP], Landry ML[SUP]18[/SUP], Neher RA[SUP]3[/SUP], Ko AI[SUP]2[/SUP], Grubaugh ND[SUP]19[/SUP].

Author information




Abstract

The novel coronavirus SARS-CoV-2 was first detected in the Pacific Northwest region of the United States in January 2020, with subsequent COVID-19 outbreaks detected in all 50 states by early March. To uncover the sources of SARS-CoV-2 introductions and patterns of spread within the United States, we sequenced nine viral genomes from early reported COVID-19 patients in Connecticut. Our phylogenetic analysis places the majority of these genomes with viruses sequenced from Washington state. By coupling our genomic data with domestic and international travel patterns, we show that early SARS-CoV-2 transmission in Connecticut was likely driven by domestic introductions. Moreover, the risk of domestic importation to Connecticut exceeded that of international importation by mid-March regardless of our estimated effects of federal travel restrictions. This study provides evidence of widespread sustained transmission of SARS-CoV-2 within the United States and highlights the critical need for local surveillance.
Copyright ? 2020 Elsevier Inc. All rights reserved.



KEYWORDS:

COVID-19; MinION sequencing; SARS-CoV-2; coronavirus; genomic epidemiology; phylogenetics; travel risk


PMID:32386545DOI:10.1016/j.cell.2020.04.021
 
Back
Top Bottom